ANI Pharma (ANIP) Misses Q4 EPS by 10c, Revenues Beat; Offers FY20 EPS/Revenue Guidance Below Consensus
Go back to ANI Pharma (ANIP) Misses Q4 EPS by 10c, Revenues Beat; Offers FY20 EPS/Revenue Guidance Below Consensus| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 82.87 +2.29 (2.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $80.58 | 52 Week High | $70.92 | |||
| Open | $81.31 | 52 Week Low | $26.80 | |||
| Day High | $82.96 | P/E | N/A | |||
| Day Low | $80.62 | EPS | $-0.96 | |||
| Volume | 143,166 | |||||
